Thuja Capital

Thuja Capital, established in 2006, is a Netherlands-based investment firm specializing in early-stage healthcare and biotech companies. It focuses on medical product innovations for diagnosis, cure, care, or prevention, including medical devices, medtech, diagnostics, therapeutics, nutraceuticals, and digital health. Thuja Capital provides seed, start-up, and early-stage financing, typically investing between €0.25 million to €2.5 million in equity and €0.50 million to €1 million in debt. The firm, based in Utrecht, considers investments across the Benelux region and Western Europe, acting as both lead and co-investor, and often takes a seat on the supervisory board.